We chose to focus on the heterozygous deletion of IRF5 in B cells given our previous finding that global heterozygous IRF5 deletion protected mice from disease to a similar extent as homozygous deletion, a finding that has been confirmed in other mouse lupus models (5, 10, 28, 29). The gene discussed is IRF5; the disease is systemic lupus erythematosus.